JP2024530839A5 - - Google Patents
Info
- Publication number
- JP2024530839A5 JP2024530839A5 JP2023578030A JP2023578030A JP2024530839A5 JP 2024530839 A5 JP2024530839 A5 JP 2024530839A5 JP 2023578030 A JP2023578030 A JP 2023578030A JP 2023578030 A JP2023578030 A JP 2023578030A JP 2024530839 A5 JP2024530839 A5 JP 2024530839A5
- Authority
- JP
- Japan
- Prior art keywords
- saponin
- oligonucleotide complex
- oligonucleotide
- saponins
- complex according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2021/050384 WO2021261992A1 (en) | 2020-06-24 | 2021-06-18 | Conjugate of galnac and saponin, therapeutic composition comprising said conjugate and a galnac-oligonucleotide conjugate |
| NLPCT/NL2021/050384 | 2021-06-18 | ||
| NLPCT/NL2021/050549 | 2021-09-09 | ||
| PCT/NL2021/050549 WO2022055351A1 (en) | 2020-09-10 | 2021-09-09 | Conjugate of saponin, oligonucleotide and galnac |
| PCT/NL2022/050127 WO2022265493A1 (en) | 2021-06-18 | 2022-03-08 | Conjugate of saponin, oligonucleotide and galnac |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024530839A JP2024530839A (ja) | 2024-08-26 |
| JP2024530839A5 true JP2024530839A5 (cg-RX-API-DMAC10.html) | 2025-03-13 |
Family
ID=80785160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578030A Pending JP2024530839A (ja) | 2021-06-18 | 2022-03-08 | サポニン、オリゴヌクレオチド、およびGalNAcの複合体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240307545A1 (cg-RX-API-DMAC10.html) |
| EP (2) | EP4591938A3 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024530839A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022265493A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118356506A (zh) * | 2023-01-17 | 2024-07-19 | 中国科学院上海药物研究所 | 去唾液酸糖蛋白受体配体与细胞毒素的偶联物及其应用 |
| GB202300865D0 (en) * | 2023-01-20 | 2023-03-08 | Proqr Therapeutics Ii Bv | Delivery of oligonucleotides |
| WO2024235273A1 (zh) * | 2023-05-15 | 2024-11-21 | 成都社泰医疗科技有限公司 | 多靶向化合物及其应用 |
| JP2026521777A (ja) * | 2023-06-21 | 2026-07-01 | サプリーム テクノロジーズ,ベー.フェー. | 中枢神経系障害を処置するための医薬組成物 |
| WO2026087680A1 (en) | 2024-10-24 | 2026-04-30 | Sapreme Technologies B.V. | Treatment for cardiovascular disease |
| WO2026087695A1 (en) | 2024-10-24 | 2026-04-30 | Sapreme Technologies B.V. | Treatment for metabolic disorder |
| WO2026087678A1 (en) | 2024-10-24 | 2026-04-30 | Sapreme Technologies B.V. | Treatment for renal disorders |
| WO2026119464A1 (en) | 2024-12-03 | 2026-06-11 | Sapreme Technologies B.V. | Treatment for cns-related disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5273965A (en) * | 1992-07-02 | 1993-12-28 | Cambridge Biotech Corporation | Methods for enhancing drug delivery with modified saponins |
| CA2522213A1 (en) * | 2003-04-08 | 2004-10-28 | Dante J. Marciani | Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| WO2011054811A1 (en) * | 2009-11-03 | 2011-05-12 | Santaris Pharma A/S | Rna antagonists targeting hsp27 combination therapy |
| KR20160083876A (ko) * | 2013-11-14 | 2016-07-12 | 로슈 이노베이션 센터 코펜하겐 에이/에스 | ApoB 안티센스 접합체 화합물 |
| EP3652190B1 (en) * | 2017-07-11 | 2023-06-14 | Freie Universität Berlin | Novel uses of a saponin and method for its isolation |
| US20220023433A1 (en) * | 2018-12-21 | 2022-01-27 | Sapreme Technologies B.V. | Saponin Conjugates |
| WO2022055351A1 (en) * | 2020-09-10 | 2022-03-17 | Sapreme Technologies B.V. | Conjugate of saponin, oligonucleotide and galnac |
-
2022
- 2022-03-08 WO PCT/NL2022/050127 patent/WO2022265493A1/en not_active Ceased
- 2022-03-08 EP EP25177636.5A patent/EP4591938A3/en active Pending
- 2022-03-08 JP JP2023578030A patent/JP2024530839A/ja active Pending
- 2022-03-08 US US18/571,599 patent/US20240307545A1/en active Pending
- 2022-03-08 EP EP22711105.1A patent/EP4355369B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kacprzak et al. | Alkaloids and isoprenoids modification by copper (I)-catalyzed Huisgen 1, 3-dipolar cycloaddition (click chemistry): Toward new functions and molecular architectures | |
| JP4365221B2 (ja) | 親水性ポリマー−マルチカルボキシルオリゴペプチドと薬剤分子との結合生成物、医薬組成物およびその薬学上の使用 | |
| Olotu et al. | An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline? | |
| EP4591938A3 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| CN104922141B (zh) | 一种用于治疗乙型病毒性肝炎的siRNA组合物 | |
| US11485752B2 (en) | Modified oligonucleotides and compound that can be used for synthesizing same | |
| Robert | Clinical pharmacokinetics of epirubicin | |
| JPH11508565A (ja) | サッカリドコンジュゲート | |
| JPH05505941A (ja) | オリゴヌクレオチド―輸送剤ジスルフィド結合体 | |
| JP2022542075A5 (cg-RX-API-DMAC10.html) | ||
| WO2023179463A1 (zh) | 阳离子脂质化合物及其制备方法和应用、以及mRNA递送系统 | |
| AU2021421161A1 (en) | Ligand compounds, conjugates, and applications thereof | |
| JP2023542500A5 (cg-RX-API-DMAC10.html) | ||
| CN101229222A (zh) | 一种减轻药物心脏毒性的甘草提取物及应用 | |
| EP4596052A3 (en) | Therapeutic combination of galnac-oligonucleotide conjugate and saponin, and uses thereof | |
| EP4529953A3 (en) | Conjugate of saponin, oligonucleotide and galnac | |
| CN101440113B (zh) | 秋水仙碱衍生物-胆汁酸偶合物及其医药用途 | |
| WO2013117149A1 (zh) | 15-苄亚基-14-脱氧-11,12-脱氢穿心莲内酯衍生物在制备保肝及抗丙肝病毒药物中的用途 | |
| CN102040516B (zh) | 白藜芦醇衍生物及其医药用途 | |
| JP5559535B2 (ja) | 薬剤をオロチン酸誘導体として投与することで薬剤の組織内濃度を下げる組成物及びその方法 | |
| CN105153259A (zh) | 以雌甾为母核的2位或16位取代的查耳酮衍生物及其制备方法和用途 | |
| JP2001253823A (ja) | Hiv遺伝子発現抑制剤 | |
| CN115671086B (zh) | 5-羟基-1,7-二苯基-3-庚酮在制备预防或治疗肝癌药物中的应用 | |
| RU2819894C1 (ru) | Лигандные соединения, конъюгаты и их применение | |
| AU2002342304B2 (en) | Agent for improving tissue penetration |